Monographie - Alfentanil hydrochloride

Ultimele actualizari :
19/11/2024

Alfentanil hydrochloride

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfenta	Iran, Peru, SUA
Alfentanil	Canada, Chilli, Columbia, Germania, Iran, Marea Britanie, SUA
Alfiject	Iran
Limifen	Spania
Rapifen	Arabia Saudita, Australia, Austria, Belgia, Chilli, Danemarca, Elvetia, Finlanda, Franta, Germania, Grecia, Irlanda, Luxemburg, Malaezia, Marea Britanie, Norvegia, noua Zeelandă, Olanda, Polonia, Portugalia, Suedia, Tunisia, Ungaria

Bibliografie : Alfentanil hydrochloride

	tip	publicare
59	ziar	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
299	ziar	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300	ziar	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319	ziar	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
660	ziar	Michaels MR, Stauffer GL, Haas DP. Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Ann Pharmacotherapy 1996 ; 30: 228-232.
815	ziar	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
921	ziar	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1625	ziar	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1712	ziar	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1713	ziar	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	ziar	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	ziar	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1861	ziar	Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J. Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture. Int J Pharm 1996 ; 127: 255-259.
1925	ziar	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
2086	ziar	Sharley NA, Burgess NG. Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes. J Pharm Pract and Res 2003 ; 33: 279-281.
3380	ziar	Eckle V-S, Heim E, Hahn M, Grasshoff C. Incompatibility of Piritramide with Cephalosporins. Ann Pharmacotherapy 2013 ;47:426-427.
3502	Laborator	Propofol (Diprivan®) - Summary of Products Characteristics Astra Zeneca 2012
3504	Laborator	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3601	Laborator	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012

Mentions Légales